相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective
Christopher P. Austin et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
The Human Phenotype Ontology in 2017
Sebastian Koehler et al.
NUCLEIC ACIDS RESEARCH (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Improving the value of clinical research through the use of Common Data Elements
Jerry Sheehan et al.
CLINICAL TRIALS (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial
Jean Bennett et al.
LANCET (2016)
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
Mario Sessa et al.
LANCET (2016)
The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network
Peter A. Merkel et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Central Institutional Review Board Review for an Academic Trial Network
Petra Kaufmann et al.
ACADEMIC MEDICINE (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
Neuroscience Networking: Linking Discovery to Drugs
Jill Heemskerk et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)